Reports

Ideas That Generate Results

Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2001-2006
Figure 2-2: Global - Pharmaceutical Market Growth (%), 2002-2006
Figure 2-3: Global - Leading Pharmaceutical Companies (in Billion US$), 2006
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2006
Figure 2-5: Global - Top Pharmaceutical Markets (in Billion US$), 2005
Figure 2-6: Global - Forecast for Top Pharmaceutical Markets (in Billion US$), 2015
Figure 2-7: Global - CAGR of Top Pharmaceutical Markets (%), 2005 to 2015
Figure 3-1: India - Nominal GDP (in Million US$), 2001-2006
Figure 3-2: India - Nominal GDP (in Million US$) 2007-2011F
Figure 3-3: India - Consumer Price Index (%), 2001-2006
Figure 3-4: India - Consumer Price Index (%), 2007-2011F
Figure 3-5: India - Currency Exchange Rates (From US$ to INR), 2001-2007
Figure 3-6: India - Foreign Direct Investment (in Billion US$), 2002-03 to 2006-07
Figure 3-7: India - Foreign Direct Investment in Pharmaceuticals (in Million US$), 2003-04 to 2006-07
Figure 3-8: India - Population (in Million), 2003-2006E
Figure 3-9: India - Population (in Million), 2007-2011F
Figure 3-10: India - Ratio of Males & Females in Population (%), 2003-2006
Figure 3-11: India - Population Breakup by Age (%), 2003-2006E
Figure 3-12: India - Population Breakup by Age (%), 2007-2011F
Figure 3-13: India - Healthcare Spending per Head (in US$), 2001-2006E
Figure 3-14: India - Healthcare Spending per Head (in US$), 2007-2011F
Figure 3-15: India - Breakup of Healthcare Payments by Source (%), 2006
Figure 3-16: India - Number of Doctors (in ‘000) 2005 & 2006E
Figure 3-17: India - Number of Doctors (in ‘000), 2007-2011F
Figure 3-18: India - Number of Nurses (in ‘000), 2004-2006E
Figure 3-19: India - Number of Nurses (in ‘000), 2007-2011F
Figure 3-20: India - Number of Hospital Beds (in ‘000), 2004-2006E
Figure 3-21: India - Number of Hospital Beds (in ‘000), 2007-2011F
Figure 3-22: India - Number of Deaths due to Leading Causes (in Numbers), 2005
Figure 3-23: India - Leading Causes of Death (%), 2005
Figure 3-24: India - Forecast for Leading Causes of Death (%), 2030
Figure 4-1: India - Pharmaceutical Market Turnover* (in Billion INR), 2001-02 to 2006-07
Figure 4-2: India - Breakup of Pharmaceutical Market (%), 2006-07
Figure 4-3: India - Pharmaceutical Exports (in Billion INR), 2000-01 to 2006-07
Figure 4-4: India - Major API Exports (in Billion INR), 2005-06
Figure 4-5: India - Major Dosage Form Exports (in Billion INR), 2005-06
Figure 4-6: India - Breakup of Pharmaceutical Exports by Region (%), 2005-06
Figure 4-7: India - Forecast for Pharmaceutical Exports (in Billion INR), 2007-08 to 2011-12
Figure 4-8: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2006-07E
Figure 4-9: India - Breakup of Pharmaceutical Imports by Group (%), 2005
Figure 4-10: India - Bulk Drugs Production* (in Billion INR), 2001-02 to 2006-07E
Figure 4-11: India - Formulations Production* (in Billion INR), 2001-02 to 2006-07E
Figure 5-1: India - Population of People above 65 Years (in Million), 2003 -2006E
Figure 5-2: India - Income Distribution among Households (%), 1989-90, 2001-02 & 2006-07E
Figure 5-3: India - Prevalence of Lifestyle Related Disorders (%), 2005
Figure 5-4: India - Share of Mass & Specialty Therapies in Pharmaceutical Market (%), 2004, 2006 & 2015F
Figure 5-5: India - Domestic Pharmaceutical Market (in Billion INR), 2001-02 to 2006-07
Figure 5-6: India - Breakup of Domestic Pharmaceutical Market by Drug Category (%), 2004
Figure 5-7: India - Forecast for Breakup of Domestic Pharmaceutical Market by Drug Category (%), 2010
Figure 5-8: India - Traditional Branded Generics Market (in Billion US$), 2004 & 2010F
Figure 5-9: India - Specialty Branded Generics Market (in Billion US$), 2004 & 2010F
Figure 5-10: India - Generic Generics Market (in Billion US$), 2004 & 2010F
Figure 5-11: India - Patented Drugs Market (in Billion US$), 2004 & 2010F
Figure 5-12: India - Breakup of Domestic Pharmaceutical Market by Therapeutic Category (%), 2006
Figure 5-13: India - Breakup of Drugs for Acute & Chronic Diseases in Domestic Pharmaceutical Market (%), 2006
Figure 5-14: Global - Biogenerics Market (in Million US$), 2006 & 2011F
Figure 5-15: India - Breakup of Pharmaceutical Market by Geographical Tier (%), 2005
Figure 5-16: India - Forecast for Breakup of Pharmaceutical Market by Geographical Tier (%), 2011
Figure 5-17: India - Number of Coronary Heart Patients (in Million), 2005 & 2015F
Figure 5-18: India - Cardiovascular Market (in Billion INR) 2005, 2006 & 2010F
Figure 5-19: India - Number of Diabetes Patients (in Million), 2005 & 2015F
Figure 5-20: India - Anti-diabetic Market (in Billion INR) 2005, 2006 & 2010F
Figure 5-21: India - Number of Asthma Patients (in Million), 2005 & 2015F
Figure 5-22: India - Anti-asthma Market (in Billion INR), 2002, 2006 & 2010F
Figure 5-23: India - Number of Obese Patients (in Million), 2005 & 2015F
Figure 5-24: India - Anti-obesity Pills Market (in Million INR), 2006 & 2010F
Figure 5-25: India - Number of Cancer Patients (in Million), 2005 & 2015F
Figure 5-26: India - Oncology Market (in Billion INR), 2005, 2006 & 2010F
Figure 5-27: India - Prevalence of HIV (%), 2002 & 2007
Figure 5-28: India - AIDS/HIV Drugs Market (in Million INR), 2001, 2006 & 2010F
Figure 5-29: Global - Countries with Maximum Number of US FDA Approved Manufacturing Plants, 2005
Figure 5-30: India - Contract Manufacturing Market (in Million US$), 2005-2010F
Figure 5-31: India - CRO Industry (in Million US$), 2006 & 2010F
Figure 5-32: India - Bioinformatics Market (in Million US$), 2002–03 to 2006-07 & 2011-12F
Figure 5-33: India - Health Insurance Market (in Billion INR), 2001-02, 2006-07 & 2011-12F
Figure 5-34: India - Drug Packaging Market (in Billion INR), 2006–07 & 2011-12F
Figure 5-35: India & Global - Proportion of Revenue Spent on R&D (%), 2005
Figure 5-36: India - Spending on R&D (in Million US$), 2000-01 to 2005-06
Figure 5-37: Global - Per Capita Drug Consumption of Top Pharmaceutical Markets (in US$), 2006
Figure 5-38: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (%), 2006
Figure 5-39: India - Income Distribution among Households (%), 2006-07 & 2011-12F
Figure 5-40: India - Forecast for Prevalence of Lifestyle Related Disorders (%), 2015
Figure 5-41: India - Population of People above 65 Years (in Million), 2007-2011F
Figure 5-42: India - Forecast for Domestic Pharmaceutical Market (in Billion INR), 2007-08 to 2011-12
Figure 6-1: India - Share of Companies in Pharmaceutical Market (%), 2006

List of Tables:

Table 2-1: Global - Leading Therapy Classes by Sale (in Billion US$), 2006
Table 2-2: Global - Leading Drugs by Sale (in Billion US$), 2006
Table 2-3: Global - Pharmaceutical Market by Region (in Billion US$), 2006
Table 4-1: India - Pharmaceutical Exports to Top Countries (in Million US$), 2003-2005
Table 4-2: India - Pharmaceutical Imports from Top Countries (in Million US$), 2003-2005
Table 5-1: India - Share of Drugs for Acute Disorders in Domestic Pharmaceutical Market (%), 2006
Table 5-2: India - Share of Drugs for Chronic Disorders in Domestic Pharmaceutical Market (%), 2006
Table 5-3: India - Launch of Patented Drugs by Product & Company
Table 5-4: India - Number of Drug Delivery Companies by Formulation Type (1999, 2003 & 2007E)
Table 5-5: India - Expansion Plans of Pharmacy Retail Chains
Table 5-6: India - Counterfeit Drugs in Domestic Pharmaceutical Market
Table 6-1: India - Performance of Top 20 Pharmaceutical Companies, 2005
Table 6-2: India - Performance of Top 20 Pharmaceutical Companies, 2006
Table 6-3: Ranbaxy Laboratories Limited - Key Financials (in Million INR), 2004-2006
Table 6-4: Cipla Limited - Key Financials (in Million INR), 2005-06 & 2006-07
Table 6-5: GlaxoSmithKline Pharmaceuticals Limited - Key Financials (in Million US$), 2005 & 2006
Table 6-6: Nicholas Piramal India Limited - Key Financials (in Million INR), 2005-06 & 2006-07
Table 6-7: Zydus Cadila - Key Financials (in Million INR), March 2004 to March 2006